Royal Marsden NHS Foundation Trust
π¬π§United Kingdom
- Country
- π¬π§United Kingdom
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
Neoadjuvant Epirubicin, Cisplatin and Capecitabine (ECX) Followed by Definitive Chemoradiation With/Without Surgery for Squamous Cell Carcinoma of the Oesophagus
Phase 2
Completed
- Conditions
- Oesophageal Carcinoma
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2009-12-16
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 16
- Registration Number
- NCT00220129
- Locations
- π¬π§
Royal Marsden Hospital, Sutton, Surrey, United Kingdom
Phase II Trial Evaluating Irinotecan and Capecitabine Relapsed/Refractory Upper GI Tumours
Phase 4
Completed
- Conditions
- Upper Gastrointestinal Tumours
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2009-12-16
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 33
- Registration Number
- NCT00220168
- Locations
- π¬π§
Royal Marsden Hospital, Sutton, Surrey, United Kingdom
Phase II Fixed Dose Rate Gemcitabine for Advanced or Metastatic Colorectal Cancer
Phase 2
Completed
- Conditions
- Colorectal Cancer
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2009-12-16
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 16
- Registration Number
- NCT00220155
- Locations
- π¬π§
Royal Marsden Hospital, Sutton, Surrey, United Kingdom
Molecular Markers of Prognosis in Colorectal Cancer Patients
Completed
- Conditions
- Colorectal Cancer
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2013-05-31
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 103
- Registration Number
- NCT00220142
- Locations
- π¬π§
Royal Marsden Hospital, Sutton, Surrey, United Kingdom
A Phase II Trial Evaluating Irinotecan Plus 5FU/LV in Patients With Relapsed/Refractory Upper GI Tumours
Phase 2
Completed
- Conditions
- Upper Gastrointestinal Tumours
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2013-05-31
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 65
- Registration Number
- NCT00220064
A Phase II Study of Oxaliplatin Capecitabine and Pre-operative Radiotherapy for Patients With Locally Advanced and Inoperable Rectal Cancer
Phase 2
Completed
- Conditions
- Rectal Cancer
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2013-05-31
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 109
- Registration Number
- NCT00220051
Pre-operative Epirubicin, Cisplatin, and Capecitabine in Patients With Newly Diagnosed Localised Oesophageal Adenocarcinoma
Phase 2
Completed
- Conditions
- Adenocarcinoma of Oesophagus
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2009-12-16
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 80
- Registration Number
- NCT00220103
- Locations
- π¬π§
Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
Determination of the Role of Microarray for Prognosis and Prediction to Chemotherapy Sensitivity in Patients With Operable, Locally Advanced and Metastatic Oesophageal Cancer
Not Applicable
- Conditions
- Oesophageal Cancer
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2015-11-25
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 400
- Registration Number
- NCT00220077
- Locations
- π¬π§
Royal Marsden Hospital, Sutton, Surrey, United Kingdom
Prospective Study in Pelvic Radiotherapy Patients
Completed
- Conditions
- Gynaecological, Urological or Rectal Cancer
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2005-09-22
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 100
- Registration Number
- NCT00220181
Nipple Aspiration, Ductal Lavage, and Duct Endoscopy For Diagnostic Assessment in Women Undergoing Surgery for Breast Cancer
Phase 2
- Conditions
- Breast Cancer
- First Posted Date
- 2004-05-17
- Last Posted Date
- 2013-08-26
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 100
- Registration Number
- NCT00083018
- Locations
- π¬π§
Royal Marsden - London, London, England, United Kingdom
Β© Copyright 2025. All Rights Reserved by MedPath